Who Owns Eupraxia Pharmaceuticals Stock?
NASDAQ: EPRXHealth CarePharmaceuticals and BiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 43.34%
- Held by insiders
- 12.11%
- Institutional holders
- 75
- Institutions 43.3%
- Insiders 12.1%
- Public and other 44.6%
Who owns Eupraxia Pharmaceuticals stock?
Institutional investors own about 43.3% of Eupraxia Pharmaceuticals's shares, spread across 75 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 12.11% of EPRX.
The largest institutional holders are Beutel, Goodman & Company Ltd (5.58%), Affinity Asset Advisors, Llc (2.54%) and Balyasny Asset Management LP (2.08%). Together, the top 10 institutions control 22.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their EPRX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EPRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Beutel, Goodman & Company Ltd | 3.63M | 5.58% | -1.1% |
| Affinity Asset Advisors, Llc | 1.65M | 2.54% | +3.8% |
| Balyasny Asset Management LP | 1.35M | 2.08% | 0.0% |
| Vivo Capital, LLC | 1.35M | 2.08% | 0.0% |
| Scotia Capital Inc. | 1.34M | 2.07% | +0.1% |
| Pfm Health Sciences, Lp | 1.21M | 1.86% | +123.8% |
| Great Point Partners LLC | 1.20M | 1.85% | 0.0% |
| Jupiter Topco LLC | 1.05M | 1.61% | +100.0% |
| Rubric Capital Management LP | 867.42K | 1.33% | +25.5% |
| Ikarian Capital, LLC | 809.74K | 1.25% | -33.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EPRX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 36.21K | 0.06% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 300 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Eupraxia Pharmaceuticals?
Beutel, Goodman & Company Ltd is the largest institutional shareholder of EPRX, owning 5.58% of shares outstanding (3.63M shares) as of its latest 13F filing.
What percentage of Eupraxia Pharmaceuticals is owned by institutions?
Institutions own about 43.3% of EPRX shares and 49.3% of the public float.
How much of Eupraxia Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 12.11% of EPRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.